Journals / Tüberküloz ve Toraks / 2020 / Cilt: 68 - Sayı: 1

Vitamin D status in hospitalized patients with chronic obstructive pulmonary disease

Hastanede yatan kronik obstrüktif akciğer hastalığı olan hastalarda D vitamini durumu

Pages
25–34
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, it did not have an association onexacerbation and long term survival.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Vitamin D deficiency and chronic obstructive pulmonary disease(COPD) are both world-wide health problems.
📊
Key Findings & Data:This study was design to evaluate theprevalence of vitamin D deficiency among patients with COPD exacerbation inrelation with surrogate markers of exacerbation and long-term mortality in hospitalized patients with COPD.Materials and Methods: 117 hospitalized COPD patients were included between January 2010 to June 2013.
💡
Conclusion & Impact:However, it did not have an association onexacerbation and long term survival.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Vitamin D deficiency and chronic obstructive pulmonary disease(COPD) are both world-wide health problems. Vitamin D has known to beimportant in infectious pathologies. However, there are conflicting results in therole of vitamin D in COPD exacerbation. This study was design to evaluate theprevalence of vitamin D deficiency among patients with COPD exacerbation inrelation with surrogate markers of exacerbation and long-term mortality in hospitalized patients with COPD.Materials and Methods: 117 hospitalized COPD patients were included between January 2010 to June 2013. Information was obtained through thepatients’ records and the electronic database of the hospital. The patients whohad on vitamin D and/or calcium therapy, and who were suspected of asthmawere excluded from the study.Results: The study included 117 patients and none of them were on vitaminD replacement on entry. The mean age was 67.95 ± 9.8 years. The number ofmale/female patients was 104/13. The mean forced expiratory volume in onesecond in percent predicted (FEV1%) was 39.97 ± 18.45. One hundred fifteen patients had vitamin D deficiency whereas only two patients had vitaminD ≥ 30 ng/dL. Seventy nine (69.5%) of the patients had severe vitamin Ddeficiency (< 10 ng/dL). The percentage of frequent exacerbators, patients who had microorganism growth and the median duration of hospital stay, mean FEV1 and survival did not differ between the groupof vitamin D < or ≥ 10 ng/dL. There was no meaningful correlation of vitamin D level and any of the surrogate markers of exacerbation.Conclusion: Severe vitamin D deficiency is heavily prevalent in Turkish COPD patients. However, it did not have an association onexacerbation and long term survival.

Özet

Giriş: Kronik obstrüktif akciğer hastalığı (KOAH)’nın ve D vitamini eksikliğinin her ikisi de dünya çapında sağlık sorunlarıdır. D vitamininin bulaşıcı patolojilerde önemli rolü olduğu bilinmektedir. Ayrıca, KOAH alevlenmesinde de D vitamininin rolü olduğu ile ilgili çelişkili sonuçlar vardır. Bu çalışma, KOAH›lı hastalarda vitamin D eksikliğinin yaygınlığını; hastanede yatan KOAH’lı hastaların alevlenme belirteçleri ve uzun dönem mortalite ile D vitamini arasındaki ilişkiyi değerlendirmek için tasarlandı. Materyal ve Metod: Ocak 2010-Haziran 2013 tarihleri arasında hastanede yatmış 117 KOAH hastası çalışmaya dahil edildi. Bilgilere hasta kayıtları ve hastanenin elektronik veri tabanı aracılığıyla ulaşıldı. D vitamini ve/veya kalsiyum tedavisi gören ve astım şüphesi alan hastalar çalışma dışı bırakıldı. Bulgular: Çalışmaya dahil edilen 117 hastanın hiçbiri D vitamini replasmanı almamaktaydı. Ortalama yaş 67.95 ± 9.8 yıl idi. Erkek/ kadın hasta sayısı 104/13’tü. Zorlu ekspirasyonun birinci saniyesinde atılan volüm (FEV1%) 39.97 ± 18.45 idi. Yüz on beş hastada D vitamini eksikliği vardı, sadece iki hastanın D vitamini ≥ 30 ng/dL idi. Hastaların 79 (%69.5)’unda ciddi D vitamini eksikliği (< 10 ng/dL) vardı. D vitamini 10 ng/dL’nin altında olan ve 10 ng/dL ve üzerinde olan gruplar arasında alevlenme sıklığı, mikroorganizma üremesi, ortalama hastanede kalma süresi, ortalama FEV1 ve sağkalım açısından farklılık saptanmadı. Vitamin D düzeyi ve alevlenmenin belirteçleri arasında anlamlı bir ilişki yoktu. Sonuç: Türkiye’de KOAH hastalarında ciddi D vitamini eksikliği oldukça yaygındır. Ancak, bunun alevlenme ve uzun süreli sağkalım ile bir ilişkisi yoktur.

🔖

Cite This Article

KOÇ, E. M., AKKALE, T. K., BAHÇECİOĞLU, S., KÖKTÜRK, N. (2022). Vitamin D status in hospitalized patients with chronic obstructive pulmonary disease. Tüberküloz ve Toraks, Cilt: 68 - Sayı: 1, 25–34. https://ajindex.com/articles/618348

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Peterlik M, Boonen S, Cross HS, Lamberg-Allardt C. Vitamin D and calcium insufficiency-related chronic diseases: an emerging world-wide public health Pproblem. Int J Environ Res Public Health 2009;6:2585-607
  2. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347-65
  3. Lips P. Vitamin D physiology. Progress in Biophysics and Molecular Biology 2006;92(1):4-8
  4. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116:2062-72
  5. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrin society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911-30
  6. Quint JK, Wedzicha JA. Is vitamin D deficiency important in the natural history of COPD? Thorax 2010;65(3):192-4
  7. Hypponen E, Power C. Hypovitaminosis D in British adults at age 45 y: nation wide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007;85:860-8
  8. Hughes DA, Norton R. Vitamin D and respiratory health. Clin Experiment Immunol 2009;158:20-5
  9. Persson LJP, Aanerud M, Hiemstra PS, Hardie JA, Bakke PS, Eagan TML. Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One 2012;7(6):e38934
  10. Zhu B, Zhu B, Xiao C, Zheng Z. Vitamin D deficiency is associated with the severity of COPD: a systematic review and meta-analysis. Int J COPD 2015;10:1907-16
  11. Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Jorgensen T, Fenger RV, et al. Vitamin D status and chronic obstructive pulmonary disease: a prospective general population study. PLoS One 2014;9(3):e90654
  12. Shoaib A, Lange P, Bojesen SE, Freiberg JJ, Nordestgaard BG. Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease. Thorax 2014;69:24-31
  13. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the Vitamin D-binding gene. Thorax 2010;65:215-20 [PubMed: 19996341]
  14. Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease. Time to Act. Am J Respir Crit Care Med 2009;179:630-6
  15. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81
  16. Chishimba L, Thickett DR, Stoc